Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients

Clinical and Experimental Allergy

Volumn 26, Issue 7, 1996, Pages 807-814

  Kowalski, M L ^a   Grzegorczyk, J ^a   Wojciechowska, B ^a   Poniatowska, M ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

aspirin sensitivity; ECP; eosinophils; mast cells; nasal washes; tryptase

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; EOSINOPHIL CATIONIC PROTEIN; LYSINE ACETYLSALICYLATE; LYSOZYME; TRYPTASE;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; EOSINOPHIL; FEMALE; HUMAN; MALE; MAST CELL; NOSE CONGESTION; NOSE POLYP; NOSE SECRETION; PRIORITY JOURNAL; PROVOCATION TEST; RHINORRHEA; SINUSITIS; SNEEZING;

EID: 0029790508     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00612.x     Document Type: Article

References (39)

1. Samter M, Beers RF. Intolerance to aspirin: Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968; 68:875-83.
2. Szczeklik A. Aspirin-induced asthma: Pathogenesis and clinical presentation. Allergy Proc 1992; 13:163-73.
3. Settipane GA. Asthma, aspirin intolerance and nasal polyps. NER Allergy Proc 1986; 7:32-7.
4. Kowalski ML. Management of aspirin-sensitive rhinosinusitis asthma syndrome: What role for aspirin desensitization? Allergy Proc 1992; 13:175-84.
5. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Brit Med J 1975; 1:67-9.
6. Christie PE, Smith C, Arm JP, Lee T. Editorial. Aspirin sensitive asthma. Clin Exp Allergy 1992; 22:171-5.
7. Spector SL, Wangaard CH, Farr RS. Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J Allergy Clin Immunol 1979; 64:500-6.
8. Jankowski R, Bene MC, Moneret-Vautrin AD et al. Immunohistological characteristics of nasal polyps. A comparison with healthy mucosa and chronic sinusitis. Rhinology suppl. 1989; 8:51-8.
9. Halopainen E, Makinen J, Paavolainen M et al. Nasal polyposis: relationship to allergy and acetylsalicylic acid intolerance. Acta Otolaryngol. 1979; 87:330-4.
10. Stevenson DD, Arroyave CM, Bhat KN, Tan NM. Oral aspirin challenge in asthmatic patients: A study of plasma histamine. Clin Allergy 1976; 6:493-506.
11. Szmidt M, Grzelewska-Rzymowska I, Rozniecki J, Kowalski M, Rychlicka I. Histaminemia after aspirin challenge in aspirin sensitive asthmatics. Agents Actions 1981; 11:105-7.
12. Ortolani C, Mirone C, Fontana A et al. Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients. Ann Allergy 1987; 59:106-12.
13. Patriarca G, Nucera E, Di Rienzo V et al. Nasal provocation test with lysine acetylsalicylate (LAS) in aspirin-sensitive patients. Ann Allergy 1991;67:60-2.
14. Pawlowicz A, Williams WR, Davies BH. Inhalation and nasal challenge in the diagnosis of aspirin-induced asthma. Allergy 1991; 46:405-9.
15. Ferreri NR, Howland WC, Stevenson DD, Spiegelberg HL. Release of leukotriens, prostaglandins and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 1988; 137:847-54.
16. Picado C, Ramis I, Rosello J et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis 1992; 145:65-9.
17. Kowalski ML, Sliwinska-Kowalska M, Igarashi Y et al. Nasal secretions in response to acetylsalicylic acid. J Allergy Clin Immunol 1993; 91:580-98.
18. Kowalski ML, Grzelewska-Rzymowska I, Szmidt M, Rozniecki J. Bronchial hyperreactivity to histamine in aspirin sensitive asthmatics: relationship to aspirin threshold and effect of aspirin desensitization. Thorax 1985; 40:598-602.
19. Raphael GD, Druce HM, Baraniuk JN, Kaliner MA. Pathophysiology of rhinitis. I. Assessment of sources of protein in metacholine-induced nasal secretions. Am Rev Respir Dis 1988; 138:413-20.
20. Kowalski ML, Grzegorczyk J, Śliwińska-Kowalska M et al. Neutrophil chemotactic activity (NCA) in nasal secretions from atopic and nonatopic subjects. Effect of antigen challenge. Allergy 1993; 48:409-14.
21. Lowry OL, Rosebrough NJ, Farr AL, Randal RJ. Protein measurement with the folin reagent. J Biol Chem 1951; 193:265-75.
22. Osserman EF, Lawlor DP. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukaemia. J Exp Med 1966; 124:921-51.
23. Raphael GD, Baraniuk JN, Kaliner MA. How and why the nose runs. J Allergy Clin Immunol 1991; 87:457-67.
24. Kowalski ML, Mossiman B, Śliwińska-Kowalska M et al. Pathophysiology of nasal mucosal response to capsaicin. Allergy Clin Immunol News 1994; suppl 2:596 (abstract).
25. Śliwinska-Kowalska M, Kowalski ML, Sulkowski W et al. Nasal responses to metabisulfite (MBS) solution in nonatopic subjects and patients with atopic rhinitis. Am J Rhinology 1994; 8:231-5.
26. Sasaki Y, Nakahara H. Granule core loss in eosinophils from a patient with aspirin induced asthma: an electron microscopic study. Ann Allergy 1989; 63:306-8.
27. Sladek K, Szczeklik A. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J 1993; 6:391-9.
28. Lozewicz S, Gomez E, Chalstrey S et al. The time course of cellular infiltration in the nasal mucosa during the immediate allergic reaction. Int Archs Allergy Appl Immunology 1991; 95:273-7.
29. Klementsson H, Venge P, Andersson M, Pipkorn U. Allergen-induced changes in nasal secretory responsiveness and eosinophil granulocytes. Acta Otolaryngol (Stockh) 1991; 111:776-84.
30. Venge P, Hakansson L, Peterson CGB. Eosinophil activation in allergic disease. Int Archs Allergy Appl Immunol 1987; 82:333-7.
31. Svensson C, Andersson M, Persson CGA et al. Albumin, Bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol 1990; 85:828-33.
32. Bisgaard H, Gronberg H, Mygind N et al. Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: Effect of glucocorticoid budesonide. J Allergy Clin Immunol 1990; 85:891-5.
33. Lozewicz S, Wang J, Duddle J et al. Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract. J Allergy Clin Immunol 1992; 89:951-7.
34. Bosso JV, Schwartz LB, Stevenson DD. Tryptase and histamine release during aspirin-induced respiratory reactions. J Allergy Clin Immunol 1991; 88:830-7.
35. Castells M, Schwartz LB. Tryptase levels in nasal-lavage fluid as an indicator of the immediate allergic response. J Allergy Clin Immunol 1988; 82:348-55.
36. Fischer AR, Rosenberg MA, Lilly CM et al. Direct evidence for the role of a mast cell in the nasal response to aspirin in aspirin-sensitive patients. J Allergy Clin Immunol 1994; 84:1045-56.
37. Christie PE, Tagari P, Ford-Hutchinson AW et al. Urinary leukotriene E4 concentrations increase after aspirin in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991; 143:1025-9.
38. Dahlen B, Kumlin M, Margolskee DJ et al. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin sensitive asthmatics. Eur Respir Dis 1993; 6:1018-26.
39. Israel E, Fischer RA, Rosenberg MA et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 1993; 148:1447-51.